投资要点： | 债券研究 | | --- | | /[Table_Date] 2025.03.09 | | | | 021-38038263 | | --- | --- | --- | | | liuyu024100@gtjas.com | | | 登记编号 | S0880523050002 | | | | 汤志宇(研究助理) | | | | 021-38031036 | | | | tangzhiyu028695@gtjas.com | | | 登记编号 | S0880123070149 | | 行情修复，消费承压 [Table_Authors] 刘玉(分析师) ——REITs 周报 本报告导读： 当前行情未调整到位下市场趋于震荡，比价逻辑下需关注其他市场对 REITs 行情的 影响。 [Table_Report] 相关报告 存单下轮行情的关键：中长期货币投放变化的时 点 2025.03.04 本轮地方债放量下的利差复盘与 3 月发行节奏展 望 2025.03.04 TS 合约的行情有何规律：关注跨品种利差和 IRR 策略 2025.03.04 转债向上仍有空间 2025.03.04 涨跌同源，静候花开 2 ...

Investment Rating - The investment rating for the company is "Accumulate" with a target price of 339.60, up from the previous forecast of 318.90 [2][14]. Core Insights - The company is expected to achieve a net profit growth of 145% year-on-year in 2024, driven by the strong momentum of its flagship product, Wei Yi Mei. The launch of the new ColNet collagen product in Q1 2025 is anticipated to further enhance growth prospects [3][14]. - The report highlights the company's robust revenue growth, with projected revenues increasing from 780 million in 2023 to 1.447 billion in 2024, representing an 85.4% increase [5][15]. - The company has a strong market position in the medical aesthetics sector, with its core product, Wei Yi Mei, expected to generate significant sales, reaching approximately 1 billion in 2025 [14]. Financial Summary - Revenue is projected to grow from 390 million in 2022 to 2.415 billion by 2026, with a compound annual growth rate (CAGR) of 23.9% [5][15]. - Net profit attributable to the parent company is expected to rise from 109 million in 2022 to 1.265 billion in 2026, reflecting a CAGR of 26.3% [5][15]. - The company's earnings per share (EPS) is forecasted to increase from 1.23 in 2022 to 14.29 in 2026 [5][15]. Market Data - The company's current market capitalization is approximately 24.341 billion, with a current share price of 275.00 [6]. - The stock has shown a 52-week price range of 143.39 to 275.00 [6]. - The company has a net asset return rate of 31.4% in 2023, projected to reach 45.9% in 2024 [5][15]. Product Development - The company plans to launch the Wei Yi Mei ColNet collagen product in February 2025, which is expected to complement its existing product line and enhance market competitiveness [14]. - The report indicates a rich pipeline of new products, including various types of collagen products that are anticipated to receive regulatory approval in 2025 [14].

股权激励锚定高增长，业务扩张加速 盈趣科技(002925) 股票研究 /[Table_Date] 2025.03.11 耐用消费品[Table_Industry] /可选消费品 | 股东权益（百万元） | 4,725 | | --- | --- | | 每股净资产（元） | 6.08 | | 市净率（现价） | 2.7 | | 净负债率 | -11.60% | [Table_PicQuote] 52周股价走势图 | | | —盈趣科技公司更新报告 | [Table_Invest] 评级： | | 增持 | | --- | --- | --- | --- | --- | --- | | [table_Authors] 刘佳昆(分析师) | | 毛宇翔(分析师) | [Table_Target] | 上次评级: | 增持 | | 021-38038184 | 021-38038672 | | 目标价格： | | 19.07 | | liujiakun029641@gtjas.com | | maoyuxiang029547@gtjas.com | | 上次预测: | 19.25 | | 登记编号S08805240 ...

煤价见底回升，预计 4 月进入上升通道 [Table_Industry] 煤炭 ——煤炭行业周报 [Table_Invest] 评级： 增持 上次评级: 增持 | [table_Authors] 黄涛(分析师) | 王楠瑀(研究助理) | | --- | --- | | 021-38674879 | 021-38032030 | | huangtao@gtjas.com | wangnanyu028176@gtjas.com | | 登记编号 S0880515090001 | S0880123060041 | 本报告导读： 3 月底非电煤需求见底，预计 4 月开启上升趋势，叠加 6 月迎峰度夏旺季驱动，价 格有望回升至 770 元/吨以上 投资要点： [投资建议： Table_Summary] 我们认为随着 3 月底煤价领先需求触底，非电煤需求（如化 工领域）逐步恢复，叠加 6 月迎峰度夏旺季驱动，价格有望回升至 770 元/吨以上。从板块推荐角度，依然推荐红利的核心中国神华、陕西煤业、 中煤能源；在政策端后续有望加码背景下焦煤板块是核心，推荐龙头淮 北矿业、平煤股份。 预计 3 月底见需求底部，4 月正式进 ...

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of 24.21 CNY, reflecting a potential upside based on current market conditions [1][12]. Core Insights - The company's annual report exceeded expectations with a cash dividend of 4.42 billion CNY, combined with a mid-year dividend of 1.46 billion CNY, totaling 5.88 billion CNY, which corresponds to an 18% dividend yield. This high dividend is expected to alleviate concerns regarding share pledges [12][13]. - The report highlights improvements in corporate governance through effective asset disposals and channel adjustments, indicating a strengthening execution capability [2][12]. - The company experienced a revenue decline of 14.5% year-on-year, with a reported revenue of 28.06 billion CNY for 2024, and a significant drop in net profit to 108 million CNY, down 95.2% [12][13]. Financial Summary - Revenue for 2023 was 32.82 billion CNY, with projections of 28.06 billion CNY for 2024, followed by a recovery to 30.77 billion CNY in 2025 [4][13]. - The net profit attributable to the parent company for 2023 was 2.27 billion CNY, with a drastic forecasted drop to 108 million CNY in 2024, before rebounding to 2.02 billion CNY in 2025 [4][13]. - The earnings per share (EPS) for 2023 was 0.93 CNY, expected to fall to 0.04 CNY in 2024, and recover to 0.83 CNY in 2025 [4][13]. Market Data - The company's stock price has fluctuated between 9.86 CNY and 17.85 CNY over the past 52 weeks, with a total market capitalization of 32.5 billion CNY [5][12]. - The company has a total equity of 24.93 billion CNY, with a book value per share of 10.23 CNY and a price-to-book ratio of 1.3 [6][12]. Future Outlook - The report anticipates continued focus on retail and new product categories, with expectations for revenue growth and profit recovery in 2025 [12][13]. - The company is expected to accelerate asset disposals in the first half of 2025, which may lead to further improvements in financial health [12][13].

公司延续双轮驱动战略，但核心增长驱动力逐步由并购增收转向内生产品增收，叠 加降本增效及子公司融合协同增利，未来有望持续赋能业绩高速增长。 投资要点： 风险提示：市场及政策变动风险，原材料价格及供应风险 | [Table_Finance] 财务摘要（百万元） | 2022A | 2023A | 2024E | 2025E | 2026E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 3,885 | 4,390 | 4,435 | 4,826 | 5,331 | | (+/-)% | 35.2% | 13.0% | 1.0% | 8.8% | 10.5% | | 净利润（归母） | 598 | 708 | 785 | 882 | 998 | | (+/-)% | 18.3% | 18.4% | 10.8% | 12.4% | 13.1% | | 每股净收益（元） | 0.95 | 1.13 | 1.25 | 1.40 | 1.59 | | 净资产收益率(%) | 15.3% | 18.5% | 20.1% | 21.8% | 23.1% | | 市盈率(现价&最 ...

Investment Rating - The report maintains an "Accumulate" rating with a target price of 217.97 CNY, unchanged from the previous forecast [2][16]. Core Views - The report emphasizes that the company is experiencing a significant increase in market share within the province, supported by strong channel advantages. The performance outlook is positive due to the strengthening of market share and channel push [3][19]. - The white liquor industry is currently in its third growth phase, transitioning from a price bubble phase to a focus on volume. This shift indicates a weakening growth potential for the sector, but leading companies can still achieve performance certainty through increased market concentration [18][19]. Financial Summary - The company’s revenue is projected to grow from 20,254 million CNY in 2023 to 27,444 million CNY in 2026, reflecting a compound annual growth rate (CAGR) of approximately 8.3% [16]. - Net profit attributable to the parent company is expected to rise from 4,589 million CNY in 2023 to 7,088 million CNY in 2026, with a CAGR of about 13.1% [16]. - Earnings per share (EPS) forecasts for 2024, 2025, and 2026 are 10.66 CNY, 12.06 CNY, and 13.41 CNY, respectively [16][18]. Market Position and Strategy - The company is effectively leveraging its strong channel push to enhance its market share in mid-tier price segments, with notable growth in established markets like Hefei [19]. - The report highlights that the company’s core advantage lies in its channel efficiency, with strong cooperation from distributors and a sustained market share increase in mature markets [19].

| | 国泰君安证券 | | --- | --- | | | GUOTAI JUNAN SECURITIES | 目 录 | | 每日报告回放（2025-03-10 09:00——2025-03-11 15:00） 2 | | | --- | --- | --- | |  | 海外策略研究：《美股情绪的反转：政策博弈是关键》2025-03-10 | 2 | |  | 行业事件快评：机器人《智元发布首个通用具身基座大模型 GO-1》2025-03-11 | 3 | |  | 行业日报/周报/双周报/月报：建材《价格修复与成本改善提升 Q1 景气预期》2025-03-11 | 3 | |  | 行业事件快评：军工《需求目标指引明确，装备建设有望加速》2025-03-11 | 4 | |  | 行业日报/周报/双周报/月报：钢铁《钢铁行业周报数据库 20250309》2025-03-10 | 5 | |  | 行业更新：基础化工《推动房地产市场回稳，地产链化工品有望受益》2025-03-10 | 6 | |  | 行业事件快评：汽车《奇瑞汽车销量高速增长，关注产业链机会》2025-03-10 | 7 ...